Literature DB >> 21216392

Abnormalities of neuronal oscillations and temporal integration to low- and high-frequency auditory stimulation in schizophrenia.

Jordan P Hamm1, Casey S Gilmore, Natalie A M Picchetti, Scott R Sponheim, Brett A Clementz.   

Abstract

BACKGROUND: Electroencephalography and magnetoencephalography studies indicate among schizophrenia patients (SZ) abnormal, often reduced, entrained steady-state (aSSR) and transient (N100/M100) neural responses to auditory stimuli. We complement this literature by focusing analyses on auditory cortices, assessing a wide range of stimulation frequencies with long driving periods and evaluating relationships between aSSR and M100 reductions in SZ.
METHODS: Seventeen SZ and 17 healthy subjects (H) participated. Stimuli were 1500 msec binaural broadband noise sequences modulated at 5, 20, 40, 80, or 160 Hz. Magnetoencephalography data were collected and co-registered with structural magnetic resonance images. The aSSRs and M100s projected into brain space were analyzed as a function of hemisphere, stimulus density, and time.
RESULTS: For aSSR, SZ displayed weaker entrainment bilaterally at low (5-Hz) and high (80-Hz) modulation frequencies. To 40-Hz stimuli, SZ showed weaker entrainment only in right auditory cortex. For M100, while responses for H increased linearly with stimulus density, this effect was weaker or absent in SZ. A principal components analysis of SZ deficits identified low (5-Hz entrainment and M100) and high (40- to 80-Hz entrainment) frequency components. Discriminant analysis indicated that the low-frequency component uniquely differentiated SZ from H. The high-frequency component correlated with negative symptoms among SZ.
CONCLUSIONS: The SZ auditory cortices were unable to 1) generate healthy levels of theta and high gamma band (80-Hz) entrainment (aSSR), and 2) augment transient responses (M100s) to rapidly presented auditory information (an index of temporal integration). Only the latter was most apparent in left hemisphere and may reflect a prominent neurophysiological deficit in schizophrenia.
Copyright © 2011 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21216392      PMCID: PMC3174270          DOI: 10.1016/j.biopsych.2010.11.021

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  55 in total

1.  Localization of human supratemporal auditory areas from intracerebral auditory evoked potentials using distributed source models.

Authors:  Blaise Yvert; Catherine Fischer; Olivier Bertrand; Jacques Pernier
Journal:  Neuroimage       Date:  2005-07-21       Impact factor: 6.556

Review 2.  Synaptic mechanisms of synchronized gamma oscillations in inhibitory interneuron networks.

Authors:  Marlene Bartos; Imre Vida; Peter Jonas
Journal:  Nat Rev Neurosci       Date:  2007-01       Impact factor: 34.870

Review 3.  Muscarinic receptors: do they have a role in the pathology and treatment of schizophrenia?

Authors:  Elizabeth Scarr; Brian Dean
Journal:  J Neurochem       Date:  2008-10-24       Impact factor: 5.372

4.  Gamma band oscillations reveal neural network cortical coherence dysfunction in schizophrenia patients.

Authors:  Gregory A Light; Jung Lung Hsu; Ming H Hsieh; Katrin Meyer-Gomes; Joyce Sprock; Neal R Swerdlow; David L Braff
Journal:  Biol Psychiatry       Date:  2006-08-07       Impact factor: 13.382

5.  Brain-state- and cell-type-specific firing of hippocampal interneurons in vivo.

Authors:  Thomas Klausberger; Peter J Magill; László F Márton; J David B Roberts; Philip M Cobden; György Buzsáki; Peter Somogyi
Journal:  Nature       Date:  2003-02-20       Impact factor: 49.962

Review 6.  GABA neurons and the mechanisms of network oscillations: implications for understanding cortical dysfunction in schizophrenia.

Authors:  Guillermo Gonzalez-Burgos; David A Lewis
Journal:  Schizophr Bull       Date:  2008-06-26       Impact factor: 9.306

7.  Schizophrenia-like GABAergic gene expression deficits in cerebellar Golgi cells from rats chronically exposed to low-dose phencyclidine.

Authors:  W Michael Bullock; Federico Bolognani; Paolo Botta; C Fernando Valenzuela; Nora I Perrone-Bizzozero
Journal:  Neurochem Int       Date:  2009-08-03       Impact factor: 3.921

8.  Cortical source estimates of gamma band amplitude and phase are different in schizophrenia.

Authors:  Peter Teale; Dan Collins; Keeran Maharajh; Donald C Rojas; Eugene Kronberg; Martin Reite
Journal:  Neuroimage       Date:  2008-06-25       Impact factor: 6.556

9.  N-methyl-d-aspartic acid receptor antagonist-induced frequency oscillations in mice recreate pattern of electrophysiological deficits in schizophrenia.

Authors:  R S Ehrlichman; M J Gandal; C R Maxwell; M T Lazarewicz; L H Finkel; D Contreras; B I Turetsky; S J Siegel
Journal:  Neuroscience       Date:  2008-10-28       Impact factor: 3.590

10.  The functional consequences of cortical circuit abnormalities on gamma oscillations in schizophrenia: insights from computational modeling.

Authors:  Kevin M Spencer
Journal:  Front Hum Neurosci       Date:  2009-10-20       Impact factor: 3.169

View more
  51 in total

1.  Reduced glutamate decarboxylase 65 protein within primary auditory cortex inhibitory boutons in schizophrenia.

Authors:  Caitlin E Moyer; Kristen M Delevich; Kenneth N Fish; Josephine K Asafu-Adjei; Allan R Sampson; Karl-Anton Dorph-Petersen; David A Lewis; Robert A Sweet
Journal:  Biol Psychiatry       Date:  2012-05-23       Impact factor: 13.382

2.  Pyramidal cell selective ablation of N-methyl-D-aspartate receptor 1 causes increase in cellular and network excitability.

Authors:  Valerie M Tatard-Leitman; Catherine R Jutzeler; Jimmy Suh; John A Saunders; Eddie N Billingslea; Susumu Morita; Rachel White; Robert E Featherstone; Rabindranath Ray; Pavel I Ortinski; Anamika Banerjee; Michael J Gandal; Robert Lin; Anamaria Alexandrescu; Yuling Liang; Raquel E Gur; Karin E Borgmann-Winter; Gregory C Carlson; Chang-Gyu Hahn; Steven J Siegel
Journal:  Biol Psychiatry       Date:  2014-07-18       Impact factor: 13.382

Review 3.  Gamma synchrony: towards a translational biomarker for the treatment-resistant symptoms of schizophrenia.

Authors:  Michael J Gandal; J Christopher Edgar; Kerstin Klook; Steven J Siegel
Journal:  Neuropharmacology       Date:  2011-02-22       Impact factor: 5.250

4.  Hierarchical organization of gamma and theta oscillatory dynamics in schizophrenia.

Authors:  Kenji Kirihara; Anthony J Rissling; Neal R Swerdlow; David L Braff; Gregory A Light
Journal:  Biol Psychiatry       Date:  2012-02-22       Impact factor: 13.382

Review 5.  Gamma band oscillations: a key to understanding schizophrenia symptoms and neural circuit abnormalities.

Authors:  James M McNally; Robert W McCarley
Journal:  Curr Opin Psychiatry       Date:  2016-05       Impact factor: 4.741

6.  Converging evidence for gamma synchrony deficits in schizophrenia.

Authors:  B J Roach; J M Ford; R E Hoffman; D H Mathalon
Journal:  Suppl Clin Neurophysiol       Date:  2013

Review 7.  The auditory steady-state response (ASSR): a translational biomarker for schizophrenia.

Authors:  Brian F O'Donnell; Jenifer L Vohs; Giri P Krishnan; Olga Rass; William P Hetrick; Sandra L Morzorati
Journal:  Suppl Clin Neurophysiol       Date:  2013

Review 8.  Neuroimaging biomarkers for early drug development in schizophrenia.

Authors:  Jason R Tregellas
Journal:  Biol Psychiatry       Date:  2013-10-04       Impact factor: 13.382

9.  Modafinil effects on middle-frequency oscillatory power during rule selection in schizophrenia.

Authors:  Michael J Minzenberg; Jong H Yoon; Yaoan Cheng; Cameron S Carter
Journal:  Neuropsychopharmacology       Date:  2014-06-26       Impact factor: 7.853

10.  Translating Adult Electrophysiology Findings to Younger Patient Populations: Difficulty Measuring 40-Hz Auditory Steady-State Responses in Typically Developing Children and Children with Autism Spectrum Disorder.

Authors:  J Christopher Edgar; Charles L Fisk; Song Liu; Juhi Pandey; John D Herrington; Robert T Schultz; Timothy P L Roberts
Journal:  Dev Neurosci       Date:  2016-01-06       Impact factor: 2.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.